GDT

Guidant (GDT)

Guidant Corp

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:GDT

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2006/04/22	02 : 02	PR Newswire (US)	Boston Scientific Completes Combination with Guidant	NYSE:GDT	Guidant Corp
2006/04/21	22 : 12	PR Newswire (US)	Abbott Completes Acquisition of Guidant Vascular Business	NYSE:GDT	Guidant Corp
2006/04/20	22 : 00	PR Newswire (US)	Boston Scientific Receives FTC Antitrust Approval for its Combination with Guidant	NYSE:GDT	Guidant Corp
2006/04/12	08 : 05	PR Newswire (US)	Standard & Poor's Announces Changes to U.S. Indices	NYSE:GDT	Guidant Corp
2006/04/12	02 : 59	PR Newswire (US)	Boston Scientific Receives European Commission's Antitrust Clearance for Guidant Transaction	NYSE:GDT	Guidant Corp
2006/04/06	06 : 34	PR Newswire (US)	Boston Scientific Signs Agreement Resolving All Outstanding Antitrust Issues With FTC Staff on Guidant Transaction	NYSE:GDT	Guidant Corp
2006/04/06	06 : 25	Business Wire	Guidant Announces Preliminary First Quarter 2006 Sales	NYSE:GDT	Guidant Corp
2006/04/01	02 : 03	PR Newswire (US)	Boston Scientific and Guidant Shareholders Each Approve Combination	NYSE:GDT	Guidant Corp
2006/03/29	22 : 00	Business Wire	Guidant to Temporarily Suspend XIENCE V Supply; Company Expects European Launch of XIENCE V in Third Quarter 2006	NYSE:GDT	Guidant Corp
2006/03/24	08 : 10	PR Newswire (US)	Boston Scientific Makes Antitrust Commitments To European Commission	NYSE:GDT	Guidant Corp
2006/03/21	21 : 30	Business Wire	Guidant Receives Independent Panel Report and Recommendations; Panel Chaired by Dr. Myerburg, an Internationally Recognized Lea	NYSE:GDT	Guidant Corp
2006/03/21	21 : 25	PR Newswire (US)	Independent Panel Commissioned by Guidant Issues Report and Recommendations	NYSE:GDT	Guidant Corp
2006/03/20	23 : 30	PR Newswire (US)	Institutional Shareholder Services Recommends That Shareholders of Boston Scientific and Guidant Approve Combination	NYSE:GDT	Guidant Corp
2006/03/17	23 : 00	Business Wire	Guidant Announces Enrollment of First Patient in Landmark Carotid Artery Stenting Study; 10,000-Patient Study Aims to Further U	NYSE:GDT	Guidant Corp
2006/03/17	04 : 30	Business Wire	Guidant to Expand Southern California Facilities; Drug Eluting and Carotid Stents, Emerging Therapies Drive Expansion	NYSE:GDT	Guidant Corp
2006/03/16	04 : 29	Business Wire	Guidant Completes Enrollment in Randomized U.S. Portion of Drug Eluting Stent Pivotal Trial; Large-Scale Trial Evaluating Safet	NYSE:GDT	Guidant Corp
2006/03/15	05 : 58	Business Wire	Guidant Announces Updated and Positive Results of Real-World Carotid Artery Stenting Study; Results from 2,500 Patients Suggest	NYSE:GDT	Guidant Corp
2006/03/13	23 : 00	Business Wire	Guidant Initiates Voluntary Worldwide Physician Communication Regarding Implantable Cardiac Defibrillators	NYSE:GDT	Guidant Corp
2006/03/11	03 : 00	Business Wire	R. Frederick McCoy, Jr., Elects Early Retirement from Guidant	NYSE:GDT	Guidant Corp
2006/03/10	02 : 00	Business Wire	Guidant Launches Innovative Cobalt Chromium Biliary Stent; RX HERCULINK ELITE Biliary Stent System Provides Superb Deliverabili	NYSE:GDT	Guidant Corp
2006/03/09	23 : 02	Business Wire	Guidant Announces Enrollment of First Patient in Clinical Trial of the World's First Fully Bioabsorbable Drug Eluting Coronary	NYSE:GDT	Guidant Corp
2006/03/07	01 : 14	PR Newswire (US)	Seven Summits Research Releases Comments on GM, RIMM, CELG, GDT, and LEXR	NYSE:GDT	Guidant Corp
2006/03/03	08 : 11	PR Newswire (US)	Boston Scientific and Guidant Proposed Merger Registration Statement Declared Effective	NYSE:GDT	Guidant Corp
2006/02/24	02 : 09	PR Newswire (US)	Boston Scientific Files Notification with European Commission	NYSE:GDT	Guidant Corp
2006/02/23	22 : 31	Business Wire	Guidant Announces Completion of FDA Inspection of St. Paul Facilities; Company Reports One Inspection Observation and Reiterates	NYSE:GDT	Guidant Corp
2006/02/07	22 : 00	Business Wire	Theregen Announces Equity Investment from Guidant Corporation to Develop Anginera(TM) Epicardial Patch	NYSE:GDT	Guidant Corp
2006/02/07	00 : 32	PR Newswire (US)	Boston Scientific Files Hart-Scott-Rodino Pre-Merger Notification	NYSE:GDT	Guidant Corp
2006/01/31	04 : 02	Business Wire	Guidant Receives European Approval for Drug Eluting Coronary Stent; Company Achieves CE Mark Approval Ahead of Schedule; XIENCE	NYSE:GDT	Guidant Corp
2006/01/27	22 : 30	Business Wire	Guidant Reports Fourth Quarter Sales of $828 Million; Full Year 2005 Sales of $3.55 Billion; Earnings from Continuing Operations	NYSE:GDT	Guidant Corp
2006/01/25	21 : 02	PR Newswire (US)	Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 Billion	NYSE:GDT	Guidant Corp